MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. The industry also encourages the development of novel pharmaceuticals and treatments, creating opportunities for Maryland residents to access cutting-edge healthcare options.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? There are many different medical cannabis products. .

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Enquiries: GW Pharmaceuticals plc.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. The products leverage pharmaceutical technology to maximize performance and safety. TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. Cannabinoids are chemical compounds found in the cannabis plant.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

Cannabis Law Report

JUNE 9, 2022

11:00-12:00 PM: Interstate Commerce: Impacts on markets, licensing, and consumer safety. Steph Sherer, Founder and President, Americans for Safe Access. 3:15-4:15 PM: Preventing Youth Access, Promoting Consumer Safety, & Protecting Public Health in State Markets. Steven Hawkins, President and CEO, U.S.

Policy 52

Policy Safety Seed-To-Sale Data 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans.

Safety 52

Safety Research and Development Compliance Compliance 52

Cannabis Law Report

SEPTEMBER 12, 2022

Our mushrooms are some of the most tested products on the planet as we cross the lines between Pharmaceutical, Agriculture, Botanical, and Food testing quality assays,” said Optimi Chief Science Officer, Justin Kirkland. To access a complete photo gallery of this historic grow, please click here. Penis Envy. Blue Pulaski.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

NOVEMBER 22, 2019

. “As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions,” said Elio Mariani, PhD, EVP of Research & Development. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

FEBRUARY 3, 2022

The Smart Event allows registered attendees to research exhibitors and products, access exclusive on-demand content, engage in live discussions and schedule meetings. The online platform will open on March 14 and is accessible to all registered visitors. Health and Safety. The press registration form is accessible here.

Packaging 52

Packaging Events Education Supply Chain 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Prior to joining Sesen Bio, Mr. Barbera served as the Vice President of Market Access at UroGen Pharma and played a critical role in the launch of the company’s first commercial product, Jelmyto ®. Julie Hoff to Vice President, Human Resources.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Easy access. But the main issue with hemp derived products and their safety is less about the CBD and more about everything else in them.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

AUGUST 31, 2020

Essay Summary: Although doctors’ offices are full of pamphlets and flyers about mainstream pharmaceuticals in both English and Spanish, there is a lack of information for Hispanic patients seeking relief with cannabis and CBD. . Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

DECEMBER 2, 2021

Safety, Ethics and Responsibilities of a Psilocybin Facilitator (10 Hours). Programs shall train students on the importance of accurate record keeping and how to maintain appropriate client records including the importance of maintaining client privacy and data security. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to provide appropriate research data. Health and safety standards for lab employees. Criterion 3. Criterion 5.

Law 40

Law Marijuana Education Safety 40

SpeedWeed

JULY 30, 2021

In my review of that book for Leafly , I charged Berenson with being a fundamentally dishonest writer, willing to purposefully and consistently distort data and provide false witness so long as it bolsters his central claim that cannabis is incredibly dangerous. So if you’re asking me where to turn for the hard data, I’d say start here.

Marijuana 52

Marijuana History Data Strains 52

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to provide appropriate research data. Health and safety standards for lab employees. Criterion 3. Criterion 5.

Law 40

Law Marijuana Education Cultivation 40

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

SpeedWeed

AUGUST 19, 2021

In recent months, a synthetic compound derived from hemp called THC-O acetate—often referred to simply as THC-O (pronounced “THC oh”)—has quickly gained popularity among Americans who don’t have access to legal cannabis. . THC-O products are increasingly popular in states where consumers don’t have access to legal cannabis.

THC 52

THC Hemp Extraction Vaping 52

Medicinal Genomics

JUNE 10, 2020

Although not mentioned in the article, Aspergillus is also an endophyte, which makes it difficult to detect with plating methods because the plant cells are not lysed to access the pathogens living inside. Michigan is now among the strictest—and the safest—states when it comes to cannabis safety testing.

Research and Development 52

Research and Development Patients Medicine Cannabis 52

Cannabis Law Report

AUGUST 19, 2019

The public health minister said that as of May 2019, only six NHS prescriptions had been written since the changes to the Regulations came into effect and ten private prescriptions were written between January 2019 and February 2019 according to the NHS Business Services Authority, which collects data on primary care. Novel Foods Regulation.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

SEPTEMBER 23, 2019

of Public Health “CDPH” – Manufactured Cannabis Safety Branch “MCSB” , California Dept. Existing law makes it a crime for any person to knowingly access, use, or disclose this confidential information without authorization. However, existing law authorizes the use of the information for specified purposes.

Legislation 40

Legislation Research and Development Programs Collective 40

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Eurofins CDMO is also planning to construct a new high potency Active Pharmaceutical Ingredient (API) facility, which is expected to be completed in April 2022, as well as a new large scale API plant in 2023 to accommodate increasing demand.

Business 105

Business Research and Development Environment Food 105

Veriheal

SEPTEMBER 23, 2021

Note: Veriheal does not support illegally consuming therapeutic substances such as Iboga but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Treatment 98

Treatment Medicine Research and Development Therapy 98

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 26, 2019

Sponsors must also ensure compliance with the relevant guidelines as to good clinical practice and safety monitoring and reporting, and ensure that the use of personal information complies with the Privacy Act 1988. The TGA does not evaluate any data relating to the trial.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

SpeedWeed

JULY 8, 2021

Manufacturers have the best opportunity to build a brand, and this makes it an attractive part of the value chain for transplanted talent from liquor, packaged goods, and pharmaceuticals because it seems familiar. . Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts.

Media 52

Media Data Retail Concentrates 52

Cannabis Law Report

DECEMBER 27, 2019

As the UK awaits the verdict of The European Food Safety Authority on whether CBD is ‘safe,’ Medical Cannabis Network caught up with food regulation specialists Katie Vickery and Katrina Anderson of Osborne Clarke to discuss the implications of the landmark decision. Reports Health Europa.

CBD 66

CBD Food Safety Data 66

Cannabis Law Report

DECEMBER 8, 2019

AJEM’s mission is to create, collect, and disseminate credible cannabis research data. 2 Advancements in understanding the ECS have not been overlooked by the general public, which has demanded both answers about cannabis as a medicine and access to it. Accessed October 12, 2019. Accessed September 23, 2019.[link]

Medicine 59

Medicine Research and Development Food Cannabinoids 59

Cannabis Law Report

MAY 13, 2019

In nearly every jurisdiction where medicinal cannabis is legal, at least one medical professional is required to sign off for a person to access it. The number of jurisdictions allowing access to medicinal cannabis has been steadily increasing since the state of California introduced legislation in 1996. Gardiner , Judith A.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Cannabis Law Report

NOVEMBER 5, 2021

Negative testing results yield a ‘green pass’ via CLEARED4 that is texted to the employee’s smartphone that authorizes access to corporate facilities. ’ Positive testing results yield a ‘red pass’ to the employee that should deny access to corporate facilities until said employee tests negative. Dr. James A.

Compliance 52

Compliance Compliance Research and Development Therapy 52